º£½ÇÉçÇø

Sir Michael Houghton is a Nobel Laureate, Professor in the Department of Medical Microbiology & Immunology and Director of the LKSIoV Applied Virology Institute, which is developing vaccines against HCV, Group A Streptococcus as well as novel drugs for Alzheimer’s. Key technological platforms available for future pandemic preparedness include adjuvanted recombinant protein GMP manufacture, advanced drug development technologies and second generation RNA technology in collaborations with Precision Nanotechnology Inc. in Vancouver, BC.